Cytogen Inc (217330) — Cash Flow-to-Debt Ratio
Cytogen Inc (217330) has a Cash Flow-to-Debt Ratio of -0.08x as of December 2025, meaning its operating cash flow of ₩-2.13 Billion could theoretically repay 0% of its total liabilities (₩26.25 Billion) in one year. Explore Cytogen Inc (217330) long-term investment share to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cytogen Inc Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Cytogen Inc across 12 annual periods. Also explore 217330 total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Cytogen Inc (2014–2025)
Year-by-year debt coverage analysis for Cytogen Inc. For market capitalisation and broader financial context, see Cytogen Inc (217330) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.26x | ₩-6.95 Billion | ₩26.25 Billion | ▲ +33.6% |
| 2024 | -0.40x | ₩-9.53 Billion | ₩23.89 Billion | ▼ -10.8% |
| 2023 | -0.36x | ₩-7.59 Billion | ₩21.09 Billion | ▼ -100.7% |
| 2022 | -0.18x | ₩-6.38 Billion | ₩35.56 Billion | ▼ -11.5% |
| 2021 | -0.16x | ₩-5.23 Billion | ₩32.52 Billion | ▲ +64.1% |
| 2020 | -0.45x | ₩-4.47 Billion | ₩9.97 Billion | ▲ +76.1% |
| 2019 | -1.88x | ₩-3.37 Billion | ₩1.80 Billion | ▲ +51.8% |
| 2018 | -3.89x | ₩-2.77 Billion | ₩711.51 Million | ▼ -69.3% |
| 2017 | -2.30x | ₩-2.18 Billion | ₩947.50 Million | ▼ -346.3% |
| 2016 | -0.52x | ₩-2.36 Billion | ₩4.59 Billion | ▲ +59.5% |
| 2015 | -1.27x | ₩-2.03 Billion | ₩1.60 Billion | ▼ -94.4% |
| 2014 | -0.65x | ₩-1.03 Billion | ₩1.57 Billion | — |